← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
AntibodystaleKite, A Gilead CompanyPhase 1

Lenzilumab (Lenzilumab)

Relapsed/Refractory Large B-cell Lymphoma · FRα

#FR#Antibody#Phase1#항체#면역항체+4
효능 ORR 9.9%임상시험 6상태 DISCONTINUED
ADCBiologicstaleAbbViePhase 3

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

Ovarian Cancer; Peritoneal Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 100%임상시험 6상태 RECRUITING
ADCBiologicGlaxoSmithKlinerezetecanPhase 3

Mocertatug rezetecan (Mocertatug rezetecan)

Ovarian Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING
ADCBiologicstaleBase Therapeutics (Shanghai) Co…Phase 2

NK510 (NK510)

NSCLC · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 RECRUITING
ADCBiologicstaleMing-Yuan ChenPhase 3

Neoadjuvant and Adjuvant Becotatug Vedotin (Neoadjuvant and Adjuvant Becotatug Vedotin)

Locally Advanced Head and Neck Squamous Cell Carcinoma · Locally Advanced Head and Neck Squamous

#LocallyAdvancedHeadandNeckSquamo#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 6상태 RECRUITING
ADCBiologicstaleSenhwa Biosciences, Inc.Phase 1

Pidnarulex (Pidnarulex)

Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8 · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING
ADCBiologicstaleRochePhase 2

Pola-R- GemOx (Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin, Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin (Pola-R- GemOx))

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 69.7%임상시험 6상태 RECRUITING
ADCBiologicstaleSorrento Therapeutics, Inc.Phase 2

STI-6129 (STI-6129)

Advanced Solid Tumor · Light Chain (AL) Amyloidosis

#LightChainALAmyloidosis#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 ACTIVE
ADCBiologicstaleTasly Pharmaceutical Group Co.,…Phase 2

STRO-002 (STRO-002)

Neoplasm Malignant · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 DISCONTINUED
ADCBiologicAstraZenecasPhase 3

Sonesitatug vedotin (Sonesitatug vedotin)

Gastric Cancer; Gastroesophageal Junction Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 6상태 ACTIVE
CGTBiologicstaleUSWM CT, LLCPhase 1

TCR-MAGE-A4 T-Cells (TCR-MAGE-A4 T-Cells)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 0%임상시험 6상태 RECRUITING
ADCBiologicstaleAstraZenecaPreclinical

TDxd (TDxd)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 6상태 RECRUITING
CGTBiologicstaleTILT Biotherapeutics Ltd.Phase 2

TILT-123 (TILT-123)

Melanoma; Head and Neck Squamous Cell Carcinoma · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 6상태 RECRUITING
AntibodystaleThe Affiliated Nanjing Drum Tow…Phase 2

Triplizumab (Triplizumab)

Bladder Cancer · Bladder Cancer

#BladderCancer#Antibody#Phase2#항체#면역항체+2
임상시험 6상태 ACTIVE
ADCBiologicstaleNeogap Therapeutics ABPhase 1

LNL (Tumor-draining lymph node-derived lymphocyte, Tumor-draining lymph node-derived lymphocyte (LNL))

Breast Neoplasms · Breast Neoplasms

#BreastNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 6상태 RECRUITING
CGTBiologicstaleiCell Gene TherapeuticsPhase 1

anti-CD5 CAR T cells (anti-CD5 CAR T cells)

T-cell Acute Lymphoblastic Leukemia; T-cell Non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 6상태 ACTIVE
CGTBiologicstaleShenzhen Geno-Immune Medical In…Phase 2

4SCAR-GD2 (4SCAR-GD2)

Solid Tumor · GD2

#GD2#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 5상태 RECRUITING
ADCBiologicstaleSichuan Kelun-Biotech Biopharma…Phase 3

A166 (A166)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 RECRUITING
CGTAAVBiologicstaleMeiraGTx UK II LtdPhase 2

AAV RPE65 (AAV RPE65)

Leber Congenital Amaurosis · Leber Congenital Amaurosis

#LeberCongenitalAmaurosis#CGT#Phase2#세포유전치료#CAR-T+2
효능 ORR 2%임상시험 5상태 ACTIVE

52 / 209 페이지

← 이전다음 →